Han‐Wook Yoo

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period

Anthony A. Portale, Thomas O. Carpenter, Maria Luisa Brandi et al. · Calcified Tissue International · 2019 · 160 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

Alberto Ortíz, Ademola K. Abiose, Daniel G. Bichet et al. · Journal of Medical Genetics · 2016 · 147 citations · Full text

Veterinary Medicine, Clinical Sciences, Pharmacotherapy +10

Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease

Eunhee Kim, Mi‐Sun Yum, Young‐Shin Ra et al. · Journal of neurosurgery · 2015 · 116 citations · Full text

Life Sciences, Genetics, Neurology +14

Identification of 15 loci influencing height in a Korean population

Jae-Jung Kim, Hae-In Lee, Taesung Park et al. · Journal of Human Genetics · 2009 · 114 citations · Full text

Life Sciences, Genetics, Genetic Epidemiology +11

PTPN11, SOS1, KRAS, and RAF1 gene analysis, and genotype–phenotype correlation in Korean patients with Noonan syndrome

Jung Min Ko, Jae‐Min Kim, Gu-Hwan Kim et al. · Journal of Human Genetics · 2008 · 108 citations

Life Sciences, Genetics, Molecular Genetics +5